Adrian Cook

National Audit Office — United Kingdom

Medicine · Health Sciences

38h-index5.8kcitations153works13.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(34), Prostate Cancer Treatment and Research(30), Prostate Cancer Diagnosis and Treatment(20), HIV/AIDS Research and Interventions(19), Intraperitoneal and Appendiceal Malignancies(18)

Publications151 total

Characteristics and outcomes of men presenting with complications of metastatic prostate cancer
British Journal of Urology·2026Open Access
10 Inequalities in access to surgical resection for non-small cell lung cancer in England: evaluation of the ‘hub and spoke’ model
Lung Cancer·2026
Future Directions of the National Prostate Cancer Audit
Clinical Oncology·2026
Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysis
International Journal of Gynecological Cancer·2025· 1 citedOpen Access
Sublobar resection or lobectomy for stage Ia non-small cell lung cancer: a systematic review and meta-analysis
BMJ Open Respiratory Research·2025· 1 citedOpen Access
1325 Evaluation of Social Determinants of Health Assessment Models in Community Pharmacy
Journal of the American Pharmacists Association·2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data
European Urology·2025· 13 citedOpen Access
1115 Are evidence-based guidelines translating into clinical practice: a national study on the use of radiotherapy to the prostate for low burden mHSPC
Radiotherapy and Oncology·2025
Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation
BMJ Oncology·2025· 6 citedOpen Access
Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in England
European Journal of Cancer·2025· 5 citedOpen Access
Difference Of Chemosensitivity Between Western And Japanese Women In First-Line Setting Of Advanced Serous Ovarian Cancer: Data From The MAOV Individual Patient Data Meta-Analysis
International Journal of Gynecological Cancer·2025
P83 Sublobar resection or lobectomy for stage 1a non-small cell lung cancer: a meta-analysis
2024
Is Centralisation of Cancer Services Associated With Under‐Treatment of Patients With High‐Risk Prostate Cancer?—A National Population‐Based Study
Cancer Medicine·2024· 3 citedOpen Access
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)
European Urology·2024· 27 citedOpen Access
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
The Lancet·2024· 45 citedOpen Access
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial
The Lancet·2024· 67 citedOpen Access
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)
Annals of Oncology·2024· 45 citedOpen Access
What can patient-reported experience measures tell us about the variation in patients’ experience of prostate cancer care? A cross-sectional study using survey data from the National Prostate Cancer Audit in England
BMJ Open·2024· 7 citedOpen Access
Organisation and delivery of supportive services for patients with prostate cancer in the National Health Service in England and Wales: a national cross-sectional hospital survey and latent class analysis
BMJ Open·2023· 2 citedOpen Access
792P Prognostic role of the modeled CA-125 KELIM in early FIGO stage I and II ovarian cancers (OC): A GCIG individual-patient data meta-analysis
Annals of Oncology·2023· 2 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Mahesh Parmar(17), Matthew R. Sydes(14), Noel W. Clarke(11), William Cross(10), Jonathan A. Ledermann(8), Nicholas D. James(8), Chris Brawley(8), Chris Parker(8), Richard Kaplan(7), Timothy Perren(7), Wendy R. Parulekar(7), Diana M. Gibb(7), Howard Kynaston(6), René Horsleben Petersen(6), Charles Catton(6), John Logue(6), Raj Persad(6), Fred Saad(6), Rakesh Raman(6), Anjali Zarkar(6)